Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Financial Performance and Strategy news
(page 8)
30 April 2026
Umicore appoints Lily Liu as CFO and Marten Zieris as Chief Digital & Transformation Officer
Outgoing CFO leaving after 20 years, advising until 28 Feb 2027. Successor has 20+ years in chemicals finance. New digital & transformation officer to lead operational excellence, digitalization and AI.
30 April 2026
TechnipFMC Q1 2026 Results
Q1 revenue $2.49B; net income $260.5M; adjusted EBITDA $466M (or $453M ex-FX); Subsea orders $1.9B; operating cash flow $332M; free cash flow $277M; $265M buyback
30 April 2026
Aptar Q1 2026 Results
Q1: sales +11% (core flat); net income -8% to $73M; EPS $1.12 (adjusted $1.19, -8% cc); adjusted EBITDA margin 2% vs 20.7%; returned $131M; Gael Touya named CEO effective Sept 1, 2026
30 April 2026
Trinseo Q1 2026 Results
Q1 sales $725M (-8%); net loss $116M; Adjusted EBITDA $53M; Free Cash Flow -$244M; ending cash/liquidity $114M; added $50M to revolver; charges $31M
30 April 2026
Petrobras resumes urea production at Ansa in Araucária, PR
Urea output resumed after 2020 hibernation following R$870M reactivation; mobilization created 2,000 jobs and ~700 ongoing; restart after ARLA‑32 and ammonia tests strengthens domestic supply
30 April 2026
Umicore Q1 momentum points to ~€1bn adjusted EBITDA in 2026
Strong Q1: Catalysis and Recycling strong; Specialty led by cobalt; CAM volumes modest, take‑or‑pay compensation; anode JV in place; capex up; leverage <2x
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
30 April 2026
Kemira Oyj: Share repurchases, week 18/2026
Repurchased 282,380 shares (Apr 27–30) at avg €17.375, total €4,906,349.13; post-buyback treasury holdings 3,783,343 shares. Buyback part of program running until Sept 20, 2026.
30 April 2026
OMV Petrom Q1 2026 Results
Strong asset output; Clean CCS EBIT 1.5bn lei (+16%); net income 1bn lei (-4%); CAPEX 1.6bn lei (+14%); state contributions 4.1bn lei (+9%); E&P down, production -3.1%; refining margin and power output rose
30 April 2026
Borouge Q1 2026: $156M Net Profit on Operational Resilience
Q1 revenue $1.2B; production 1.21Mt (98% capacity), sales 1.09Mt. 61% of March output rerouted via alternative logistics. Prices rose 62% in March. H2 2025 dividend $658M; merger forms global polyolefins platform.
30 April 2026
BASF Q1 2026: resilient performance
Solid volume growth offset currency headwinds; EBITDA before special items €2.4bn (vs €2.5bn). Sales slightly down; free cash flow -€1.375bn. Dividend €2.25; outlook unchanged.
30 April 2026
Technip Energies Q1 2026 Results
>€6bn orders, backlog >€20bn; revenue €1.8bn, EBITDA €149m, FCF €132m (89% conv). Middle East disruptions defer €500–600m; Project Delivery guidance cut to €5.7–6.3bn; TP&S steady.
30 April 2026
Moody’s Affirms ORLEN A3 Rating
Moody's notes strong liquidity and baa2 BCA with stable outlook. Solid balance sheet and cash flows can fund capex and dividends. Diverse supply, flexible trading and 2026 projects boost resilience.
30 April 2026
Eli Lilly Q1 2026: Revenue up 56%, raises full‑year guidance
EPS jumped ~170% reported (~156% non‑GAAP); volume growth offset lower realized prices; FDA approved oral GLP‑1 Foundayo; positive Phase‑3 readouts; four acquisitions announced
30 April 2026
Merck & Co Q1 2026 Results — Sales Growth, Regulatory Approvals and Clinical Milestones
Q1 revenue $16.3B; KEYTRUDA $8.0B. GAAP loss $1.72/sh, non-GAAP loss $1.28/sh after $9.0B Cidara charge. Announced Terns acquisition; raised 2026 sales to $65.8-67.0B and non-GAAP EPS $5.04-5.16
30 April 2026
OMV: Clean CCS operating result ~EUR 1.0bn in Q1 2026
Q1: operating cash flow €776m (€1,624m excl NWC, +20%); net income €323m; leverage 17%. Energy down, Fuels flat, Chemicals up on Borealis reclass. and higher polyolefin margins; Borouge closed
29 April 2026
SABIC Q1 2026 results
Q1: adjusted EBITDA +25% to SAR4.15bn; revenue -6% to SAR26.15bn; adjusted net income SAR816m; realized $220m recurring EBITDA savings; divestments announced; urea capacity could rise 54%
29 April 2026
GSK Q1 2026 — Specialty Medicines Drive Growth
Q1 sales £7.6bn (+5% CER); Specialty Medicines £3.2bn (+14%). Core operating profit +10%, Core EPS +9%. Strong cash generation; 17p Q1 dividend. 2026 guidance and >£40bn 2031 target reaffirmed.
29 April 2026
MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed
Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share
29 April 2026
UPM approves Plywood demerger to create listed WISA Group
Board approved plan to spin off a business into a new listed company; EGM approval pending; 1:1 share distribution; target completion Oct 31, 2026; listing expected early Nov 2026.
29 April 2026
ROSI raises €20m+ to scale PV recycling in Europe
€20M+ plus EU grants to fund industrial expansion: 10,000 t/yr solar-panel recycling plant in Spain, scalable automated line, new production director appointed, recycling partnership renewed
29 April 2026
BASF’s industrial Cathedral and the ground it stands on
Integrated site captured synergies for decades—cutting costs, funding R&D—but gas-price shock in 2022 exposed systemic risk; response: restructure Ludwigshafen and expand production abroad.
29 April 2026
UPM Q1 2026: Strong start led by decarbonization solutions
Q1 sales €2,505m; comparable EBIT €274m (-5%); operating cash flow €89m; net debt €2,962m. Energy and biofuels strong. H1 comparable EBIT guidance €325–525m.
29 April 2026
FUCHS starts 2026 strongly amid volatile markets
Q1 sales +1% to €934m; record EBIT €125m; EPS €0.68 (+15%). FY EBIT target €450m confirmed; sales guidance above €3.7bn. Raw‑material and supply risks weigh on cash flow.
29 April 2026
TotalEnergies completes 50% acquisition of EPH flexible power portfolio in Europe
Creates TTEP: 14 GW flexible gas/biomass + BESS across Italy, UK, Ireland, Netherlands, France; ~30 TWh output in 2025; tolling contracts; 5 GW development pipeline.
29 April 2026
TotalEnergies Q1 2026 Results
Press release (Paris, Apr 29, 2026) announcing financial results; links to full details and investor information.
29 April 2026
Symrise Q1 2026: Organic sales -0.4%, full-year outlook reaffirmed
Strength in Food & Beverage, Pet Food, Fragrance; Taste, Nutrition & Health +1.7%, Scent & Care -3.4%. ONE SYM driving cost savings and reinvestment; APAC & Americas up, EMEA down
29 April 2026
Neste Q1 2026 Interim Report
Strong Q1: comparable EBITDA EUR 861m; cash flow before financing EUR 286m; renewable margin USD 856/t; oil refining margin USD 23.0/bbl; leverage 31.7%; volumes hit by maintenance
28 April 2026
PPG Q1 2026 results
Q1 net sales $3.93B (+7%), organic +1% on price. Adjusted EPS $1.83 (+6%). Segment margin 16%, EBITDA margin 19%. ~$100M buybacks. Reaffirms FY EPS $7.70–8.10.
28 April 2026
Air Liquide Q1 2026: growth and record investments
Q1 sales €6.8B (+3.4% ex-currency/energy). Gas & Services +2%; Healthcare +4%. Efficiencies €142M; operating cash flow +7%. Investments €1.5B, backlog €5.5B; DIG Airgas closed; +100bps margin target 2026.
28 April 2026
bp Q1 2026 results
Q1: upstream and downstream reliability rose; underlying RC profit $3.2B; operating cash flow $2.9B after $6.0B working-cap build; net debt $25.3B; Gelsenkirchen sale agreed.
← Previous
Next →
